Long-Term Safety of Tocilizumab in Patients with Rheumatoid Arthritis and a Mean Treatment Duration of 3.7 Years. Genovese, M. C., Sebba, A., Rubbert-Roth, A., Jose Scali, J., Alten, R., Kremer, J. M., Pitts, L., Vernon, E., van Vollenhoven, R. F. WILEY-BLACKWELL. 2012: S700–S701

View details for Web of Science ID 000309748303361